Combined chronic administration of methotrexate and cyclosporine A following cardiac ongoing rejection.
Forni
A
A
Division of Cardiac Surgery, University of Verona, Italy.
Faggian
G
G
Chiominto
B
B
Mazzucco
A
A
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D007958:Leukocyte Count / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone; D008727:Methotrexate